Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
17 Marzo 2025 - 9:05PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of March, 2025
Commission
File Number: 001-41798
SIMPPLE
LTD. |
(Registrant’s
Name) |
71
Ayer Rajah Crescent
#03-07
Singapore
139951
(Address
of Principal Executive Offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIMPPLE
LTD. (“we,” “our,” “us,” or the “Company”) held an extraordinary general meeting (the
“Meeting”) of shareholders at 9:00 pm., Singapore time on December 9, 2024, virtually at the following link: www.virtualshareholdermeeting.com/SPPL2024SM.
Each ordinary share of the Company is entitled to one vote. Holders of a total 12,950,778 ordinary shares issued and outstanding and
entitled to vote at the Meeting have voted. Therefore, a quorum of a majority of the ordinary shares outstanding and entitled to vote
at the Meeting as of the record date of October 25, 2024 was reached. The final voting results for each matter submitted to a vote of
shareholders at the meeting are as follows:
Proposal
1
For
a special resolution to be passed to replace the existing amended and restated:
That
the existing amended and restated memorandum and articles of association of the Company dated 29 September 2022 (and as further amended
by a special resolution of the Company passed on 21 October 2022) be and are hereby replaced with a new amended and restated memorandum
and articles of association, in the form circulated to the shareholders prior to the meeting, with effect from 13 December 2024 (the
“Amended and Restated Memorandum and Articles of Association”).
For |
|
Against |
|
Abstain |
12,946,568 |
|
4,210 |
|
0 |
Proposal
2
For
an ordinary resolution to be passed to consolidate the Company’s authorised share capital:
That:
|
(i) |
18,625,961
issued ordinary shares of a nominal or par value of US$0.0001 each held by the existing shareholders of the Company be consolidated
into 2,328,246 ordinary shares of a nominal or par value of US$0.0008 each, having the rights set out in the Amended and Restated
Memorandum and Articles of Association, with effect from 13 December 2024; |
|
|
|
|
(ii) |
481,374,039
authorized but unissued ordinary shares of a nominal or par value of US$0.0001 each in the capital of the Company be consolidated
into 60,171,754 ordinary shares of a par value of US$0.0008 each, having the rights set out in the Amended and Restated Memorandum
and Articles of Association, with effect from 13 December 2024; |
|
|
|
|
(iii) |
no
fractional shares be issued in connection with the share consolidation and, in the event that a shareholder would otherwise be entitled
to a fractional share upon the share consolidation, the total number of shares to be received by such shareholder may be rounded
up to the nearest whole number, with effect from 13 December 2024; and |
|
|
|
|
(iv) |
as
a consequence of the above, the authorised share capital of the Company will be changed with effect from 13 December 2024: |
FROM:
US$50,000 divided into 500,000,000 ordinary shares of a nominal or par value of US$0.0001 each,
TO:
US$50,000 divided into 62,500,000 ordinary shares of a nominal or par value of US$0.0008 each.
For |
|
Against |
|
Abstain |
12,935,628 |
|
4,214 |
|
10,936 |
Proposal
3
For
an ordinary resolution to be passed to approve the ancillary documents, actions and ratification:
|
(i) |
that
the Company gives, makes, signs, executes and delivers all such agreements, letters, notices, certificates, acknowledgements, instructions
and other documents (whether of a like nature or not) (the “Ancillary Documents”) as may be considered necessary or desirable
by any director for the purpose of compliance with any condition precedent or the coming into effect of or otherwise giving effect
to, consummating or completing or procuring the performance and completion of all or any of the matters described in this meeting; |
|
|
|
|
(ii) |
that
the Ancillary Documents be in the form as any director may approve; |
|
|
|
|
(iii) |
that
any director be authorised to sign any Ancillary Document on behalf of the Company (as a deed or under seal if required) together
with such amendments to those Ancillary Documents as that director considers necessary or desirable (the signature of any director
on any Ancillary Document being conclusive evidence of that director’s approval of the Ancillary Document on behalf of the
Company); |
|
|
|
|
(iv) |
that
all of the Ancillary Documents be valid, conclusive, binding on and enforceable against the Company when approved, executed and delivered
in the manner set out in these minutes; |
|
|
|
|
(v) |
that
any director be authorised to do any other acts or things that the directors consider necessary or desirable in order to implement
the matters referred to in this meeting; and |
|
|
|
|
(vi) |
that
anything that has been contemplated by the above resolutions and which has been done on behalf of the Company on or before the date
this meeting be and are adopted, ratified, confirmed and approved on behalf of the Company in all respects. |
For |
|
Against |
|
Abstain |
12,946,964 |
|
3,814 |
|
0 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
SIMPPLE
LTD. |
|
|
|
Date:
March 17, 2025 |
By: |
/s/
Schroeder Norman |
|
Name:
|
Schroeder
Norman |
|
Title:
|
Chief
Executive Officer and Director |
Grafico Azioni SIMPPLE (NASDAQ:SPPL)
Storico
Da Mar 2025 a Apr 2025
Grafico Azioni SIMPPLE (NASDAQ:SPPL)
Storico
Da Apr 2024 a Apr 2025